Clinical Trial for Patients in the United States and Canada
Vertex Spring Trial

Enrollment Requirements for the SPRING Trial

Participation Requirements

VX-210 study researchers are seeking newly injured people with acute traumatic neck area spinal cord injury to participate in a clinical research study evaluating the efficacy and safety of an investigational therapy, VX-210, which is applied to the spinal cord during initial decompression/stabilization surgery.

Selected Key Participation Criteria:

Men or women 14 to 75 years of age

Have experienced an acute traumatic spinal cord injury (SCI) in the neck area (C4, C5, or C6 motor level on each side), and American Spinal Injury Association Impairment Scale (AIS) grade A or AIS grade B

Are scheduled and planned to undergo an initial spinal decompression/stabilization surgery starting within 72 hours after the initial injury

These are not the only criteria for entering the study. The study has additional participation criteria that will be reviewed with potential participants by the clinical site investigators.

Learn more about the enrollment requirements for the SPRING Trial on ClinicalTrials.gov

This website contains information related to general medical conditions and is provided for educational purposes only. It is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

The study described here investigates treatments or outcomes that have not received regulatory approval from a health authority. The information presented here is not meant to convey conclusions of safety or effectiveness. There is no guarantee that the outcome of this trial will result in approval by a regulatory authority. The information about the SPRING Trial used in this website comes from ClinicalTrials.gov.